G1 Therapeutics
0 followers
G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA™ (Trilaciclib).
Org chart
Raj Malik
Chief Medical Officer
Monica Thomas
General Counsel & Chief Compliance Office
Whitney Page
Chief Of Staff And Senior Director Of Corporate Development
Amanda Jacobson
Senior Director Clinical Science
Sandi James
Director, Legal
Will Roberts
VP, Investor Relations & Corporate Communications
Greg Maxfield
VP, Market Access
Daniel Barnes
Senior Director, Marketing
Darlene Burns
Director, Key Customer Marketing
Shannon Lusk
Sr Director, Commercial Operations
Daren Hill
Sr. IT Help Desk Analyst
Jeremy Paul Ware
Senior Manager Commercial Supply Chain & Logistics
Annie McCoy
Associate Director, Statistical Programming
Olu O. Oyeneye
Sr Infrastructure /DevOps Eng.
Mike Townsend
Principal Solutions Architect
